stockrowChina Pharma Holdings, Inc. (CPHI) vs SCYNEXIS, Inc. (SCYX)
- China Pharma Holdings, Inc. CPHI 0.57 +7.55%
- SCYNEXIS, Inc. SCYX 3.47 +5.15%
China Pharma Holdings, Inc. and SCYNEXIS, Inc. are both Drug Manufacturers Specialty & Generic companies. SCYNEXIS, Inc. is the larger, with a market value of $32.8M against $22.8M — 1.4× the size. SCYNEXIS, Inc. grew revenue faster over the last twelve months: 682.5% against −11.0%. SCYNEXIS, Inc. has the higher net margin (−49.7% vs −114.3%) and the lower return on invested capital (−110.7% vs −7.23%). Across the 18 metrics below, SCYNEXIS, Inc. leads on 13 and China Pharma Holdings, Inc. on 5.
Valuation
Profitability
| Metric | CPHI | SCYX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 11.76% | 100.00% | 53.51% |
| Operating margin | (111.84%) | (109.90%) | 0.00% |
| Net margin | (114.33%) | (49.74%) | (2.45%) |
| Free cash flow margin | (3.59%) | (64.67%) | 0.00% |
| Return on equity | (20.99%) | (18.38%) | (0.80%) |
| Return on assets | (15.30%) | (15.09%) | (1.67%) |
| Return on invested capital | (7.23%) | (110.72%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack